Trial
NCT01310738
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Brasilia
Collaborators
Ministry of Health, Brazil; Drugs for Neglected Diseases; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Condition
Visceral Leishmaniasis
Intervention
Antimoniate of N-methylglucamine
Why stopped
DSMB recommendation based on programmed interim analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-05